Learn more

CHENGDU KADIFU TECH CO LTD

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    142,196
About

CHENGDU KADIFU TECH CO LTD has a total of 12 patent applications. Its first patent ever was published in 2015. It filed its patents most often in China. Its main competitors in its focus markets organic fine chemistry and chemical engineering are BONRATH WERNER, HALCON INTERNATIONAL INC and ZIBO QIXIANG TENGDA CHEMICAL CO LTD.

Patent filings in countries

World map showing CHENGDU KADIFU TECH CO LTDs patent filings in countries
# Country Total Patents
#1 China 12

Patent filings per year

Chart showing CHENGDU KADIFU TECH CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Liao Runai 11
#2 Liao Ruer 1

Latest patents

Publication Filing date Title
CN106140063A A kind of antistatic additive intermediate ethanol ether phosphoric acid monoesters process units
CN105771853A Production device of surfactant intermediate dodecyl dimethyl amine oxide
CN105753749A Production device of polyacrylonitrile fiber synthetic fiber static electricity remover intermediate trimethylethoxylethylene methylammonium sulfate
CN105777566A Production method of gel emulsifier intermediate N-dodecyl betaine
CN105771852A Production device of triethanolamine monostearate as processing aid intermediate of phthalocyanine pigment
CN105753893A Device for producing fatty acid glycerol borate serving as intermediate of chemical fiber processing emulsifier
CN105461568A Synthesis method of bromhexine drug intermediate N-methyl-N-o-nitro benzyl cyclohexylamine
CN105461607A Synthetic method of pindolol medicine intermediate (I)-4-(2-hydroxyl-3-isopropyl amino propoxy)indole
CN105461558A Synthesis method of phenylbutazone drug intermediate diethyl n-butylmalonate
CN105461576A Synthetic method of Oxazolam drug intermediate 2-amino-5-chlorobenzophenone
CN105461527A Synthesis method of efloxate drug intermediate 3, 4-dihydroxyacetophenone
CN105461653A Synthetic method of piroxicam drug intermediate 3-oxo-1,2-benzisothiazole-1,1-dioxo-2-ethyl acetate